632 followers
The surge of HBsAb level in a HBsAg-negative ES-SCLC patient after anlotinib plus atezolizumab treatment: A case report https://t.co/3iskHiyRVL
The surge of HBsAb level in a HBsAg-negative ES-SCLC patient after anlotinib plus atezolizumab treatment: A case report https://t.co/3iskHiyRVL
New research: The surge of HBsAb level in a HBsAg-negative ES-SCLC patient after anlotinib plus atezolizumab treatment: A case report: Small-cell lung cancer (SCLC) is a poorly differentiated neuroendocrine tumor with endocrine function. For… https://t.co/